Peter M. J. Quinn

NewYork–Presbyterian Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.4kcitations59works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Development and Disorders(49), CRISPR and Genetic Engineering(17), Retinal Diseases and Treatments(12), Virus-based gene therapy research(9), Photoreceptor and optogenetics research(5)

Publications59 total

Prime editing for the investigation of aberrant splicing defect associated with a pathogenic PRPH2 variant
Molecular Therapy — Nucleic Acids·2025· 2 citedOpen Access
Eyes shut homolog (EYS): Connecting molecule to disease
Progress in Retinal and Eye Research·2025· 1 citedOpen Access
Phenotypic spectrum and theoretical prime editing analysis of WDR19-mediated retinal degeneration
Documenta Ophthalmologica·2025Open Access
Ablating VHL in rod photoreceptors modulates RPE glycolysis and improves preclinical model of retinitis pigmentosa
Journal of Clinical Investigation·2025· 5 citedOpen Access
Megabase Deletion of the Human EYS Locus Using CRISPR/Cas9
Advances in experimental medicine and biology·2025· 1 cited
Prime Editing Strategy to Install the Mfrp Retinal Degeneration 6 Mutation
Advances in experimental medicine and biology·2025· 1 cited
Genetic Landscape of Nonsyndromic Retinitis Pigmentosa in Portugal
Advances in experimental medicine and biology·2025· 2 cited
Generation of Retinal Organoids Using Human-Induced Pluripotent Stem Cells
Methods in molecular biology·2025
Prime Editing Strategy to Install the RPE65 c.1430A>G Dominant Mutation
Advances in experimental medicine and biology·2025· 3 cited
Targeting miR-181a/b in retinitis pigmentosa: implications for disease progression and therapy
Cell & Bioscience·2024· 5 citedOpen Access
Human CRB1 and CRB2 form homo- and heteromeric protein complexes in the retina
Life Science Alliance·2024· 5 citedOpen Access
Characterization and AAV-mediated CRB gene augmentation in human-derived CRB1KO and CRB1KOCRB2+/− retinal organoids
Molecular Therapy — Methods & Clinical Development·2023· 9 citedOpen Access
A novel pathogenic CRB1 variant presenting as Leber Congenital Amaurosis 8 and evaluation of gene editing feasibility
Documenta Ophthalmologica·2023· 1 citedOpen Access
CRB1 is required for recycling by RAB11A+ vesicles in human retinal organoids
Stem Cell Reports·2023· 8 citedOpen Access
TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic Status
Antioxidants·2023· 7 citedOpen Access
Clinical and Therapeutic Evaluation of the Ten Most Prevalent CRB1 Mutations
Biomedicines·2023· 14 citedOpen Access
<scp>HIF2α</scp> activation and mitochondrial deficit due to iron chelation cause retinal atrophy
EMBO Molecular Medicine·2023· 28 citedOpen Access
Generation of an Avian Myeloblastosis Virus (AMV) Reverse Transcriptase Prime Editor
Advances in experimental medicine and biology·2023· 5 cited
Prime Editing Strategy to Install the PRPH2 c.828+1G&gt;A Mutation
Advances in experimental medicine and biology·2023· 7 cited
Generation of CRB1 RP Patient-Derived iPSCs and a CRISPR/Cas9-Mediated Homology-Directed Repair Strategy for the CRB1 c.2480G&gt;T Mutation
Advances in experimental medicine and biology·2023· 7 cited
page 1 of 3Next →

Frequent Co-authors

Stephen H. Tsang(20), C. Henrique Alves(16), Jan Wijnholds(16), Bruna Lopes da Costa(16), Sarah R. Levi(9), Salvatore Marco Caruso(9), Yi‐Ting Tsai(8), Thilo M. Buck(6), Rogier M. Vos(6), Laura A. Jenny(6), António Francisco Ambrósio(5), Lucie P. Pellissier(5), Yao Li(5), Nicholas D. Nolan(5), Nan‐Kai Wang(4), Aat A. Mulder(4), Charlotte Ohonin(4), Harald Mikkers(4), Camiel J. F. Boon(4), Abraham J. Koster(4)